105 0

Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still’s disease a case report

Title
Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still’s disease a case report
Author
이병로
Keywords
Adult-onset Still's disease; Case report; Dexamethasone implants; Intravitreal injection; Scleritis; Uveitis
Issue Date
2016-11
Publisher
BIOMED CENTRAL LTD
Citation
BMC OPHTHALMOLOGY, v. 16, Page. 196-199
Abstract
Background: Adult-onset Still's disease is a systemic inflammatory disease which presents with uveitis and scleritis in the eye. Intravitreal dexamethasone implants are used for the treatment of refractory uveitis. Case presentation: A 19-year-old woman diagnosed to have adult-onset Still's disease for fevers, joint pain, and a salmon-colored bumpy rash presented with scleritis and uveitis in the left eye. Topical and systemic steroids with oral methotrexate failed to control the inflammation. We performed intravitreal injections of dexamethasone implants for side effects of steroid and refractory ocular inflammation. The therapy resulted in improvements in the patient's uveitis with reductions in scleral vessel engorgement and redness. There was no recurrence of uveitis or scleritis during 4 months following treatment. Conclusions: Intravitreal injections of dexamethasone implants may result in clinical improvements of refractory scleritis combined with uveitis.
URI
https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-016-0380-4https://repository.hanyang.ac.kr/handle/20.500.11754/101148
ISSN
1471-2415
DOI
10.1186/s12886-016-0380-4
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE